Literature DB >> 17060659

Diagnosis and treatment of deep-vein thrombosis.

Dimitrios Scarvelis1, Philip S Wells.   

Abstract

Deep-vein thrombosis (DVT) is a common condition that can lead to complications such as postphlebitic syndrome, pulmonary embolism and death. The approach to the diagnosis of DVT has evolved over the years. Currently an algorithm strategy combining pretest probability, D-dimer testing and compression ultrasound imaging allows for safe and convenient investigation of suspected lower-extremity thrombosis. Patients with low pretest probability and a negative D-dimer test result can have proximal DVT excluded without the need for diagnostic imaging. The mainstay of treatment of DVT is anticoagulation therapy, whereas interventions such as thrombolysis and placement of inferior vena cava filters are reserved for special situations. The use of low-molecular-weight heparin allows for outpatient management of most patients with DVT. The duration of anticoagulation therapy depends on whether the primary event was idiopathic or secondary to a transient risk factor. More research is required to optimally define the factors that predict an increased risk of recurrent DVT to determine which patients can benefit from extended anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060659      PMCID: PMC1609160          DOI: 10.1503/cmaj.060366

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  60 in total

1.  Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Martin H Prins; Enrico Bernardi; Antonio Marchiori; Paola Bagatella; Michela Frulla; Laura Mosena; Daniela Tormene; Andrea Piccioli; Paolo Simioni; Antonio Girolami
Journal:  Ann Intern Med       Date:  2002-12-17       Impact factor: 25.391

2.  Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.

Authors:  P O Hansson; J Sörbo; H Eriksson
Journal:  Arch Intern Med       Date:  2000-03-27

Review 3.  Chronic thromboembolic pulmonary hypertension.

Authors:  P F Fedullo; W R Auger; R N Channick; K M Kerr; L J Rubin
Journal:  Clin Chest Med       Date:  2001-09       Impact factor: 2.878

Review 4.  Plasma D-dimers in the diagnosis of venous thromboembolism.

Authors:  James Kelly; Anthony Rudd; Roger R Lewis; Beverley J Hunt
Journal:  Arch Intern Med       Date:  2002-04-08

Review 5.  Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

Authors:  C J van Dongen; M R Mac Gillavry; M H Prins
Journal:  Cochrane Database Syst Rev       Date:  2003

6.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Authors:  Agnes Y Y Lee; Mark N Levine; Ross I Baker; Chris Bowden; Ajay K Kakkar; Martin Prins; Frederick R Rickles; Jim A Julian; Susan Haley; Michael J Kovacs; Michael Gent
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

7.  A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosis.

Authors:  Shannon M Bates; Clive Kearon; Mark Crowther; Lori Linkins; Martin O'Donnell; Jim Douketis; Agnes Y Y Lee; Jeffrey I Weitz; Marilyn Johnston; Jeffrey S Ginsberg
Journal:  Ann Intern Med       Date:  2003-05-20       Impact factor: 25.391

Review 8.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Fibrin fragment D-dimer and the risk of future venous thrombosis.

Authors:  Mary Cushman; Aaron R Folsom; Lu Wang; Nena Aleksic; Wayne D Rosamond; Russell P Tracy; Susan R Heckbert
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

View more
  33 in total

1.  Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.

Authors:  Laura McCullagh; Cathal Walsh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

2.  Contrast sonovenography - Is this the answer to complex deep vein thrombosis imaging?

Authors:  Agw Smith; P Parker; O Byass; K Chiu
Journal:  Ultrasound       Date:  2016-01-19

3.  57-year-old woman with acute lower extremity pain and swelling.

Authors:  Elizabeth Coss; Jeffrey B Geske; Paul S Mueller
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

4.  The management of venous thromboembolism: A practical tool for the front-line clinician.

Authors:  Tammy J Bungard; William Semchuk
Journal:  Can Pharm J (Ott)       Date:  2017-02-09

5.  A Bayesian Hierarchical Summary Receiver Operating Characteristic Model for Network Meta-analysis of Diagnostic Tests.

Authors:  Qinshu Lian; James S Hodges; Haitao Chu
Journal:  J Am Stat Assoc       Date:  2018-08-07       Impact factor: 5.033

6.  Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases.

Authors:  Sulhattin Arslan; Sinasi Manduz; Kürşat Epöztürk; Oğuz Karahan; Ibrahim Akkurt
Journal:  Mol Biol Rep       Date:  2010-11-16       Impact factor: 2.316

7.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

8.  Deep Vein Thrombosis in Elderly Patients following Surgery for Fracture of the Proximal Femur.

Authors:  R Magetsari; P Dewo; A S Nugroho; Z Lanodiyu
Journal:  Malays Orthop J       Date:  2014-11

9.  Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.

Authors:  Joseph A Delaney; Lucie Opatrny; James M Brophy; Samy Suissa
Journal:  CMAJ       Date:  2007-08-14       Impact factor: 8.262

Review 10.  Deep vein thrombosis: current status and nanotechnology advances.

Authors:  Aniket S Wadajkar; Sonia Santimano; Maham Rahimi; Baohong Yuan; Subhash Banerjee; Kytai T Nguyen
Journal:  Biotechnol Adv       Date:  2012-08-23       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.